INVO Bioscience Inc.

NASDAQ: INVO · Real-Time Price · USD
0.83
-0.02 (-2.35%)
At close: Oct 21, 2024, 10:00 PM

INVO Bioscience Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-0.00 -0.26 -0.47 -5.32
PEG Ratio
-0.00 0.00 -0.01 0.09
PS Ratio
0.00 0.70 6.25 8.51
PB Ratio
0.00 2.37 -5.26 4.84
P/FCF Ratio
-0.00 -0.41 -0.78 -5.46
P/OCF Ratio
-0.00 -0.44 -0.78 -5.87
OCF/S Ratio
-0.46 -1.57 -8.03 -1.45
Debt / Equity Ratio
0.85 9.73 -2.73 0.29
Quick Ratio
0.06 0.12 0.10 4.80
Current Ratio
0.07 0.15 0.18 5.03
Asset Turnover
0.14 0.14 0.20 0.40
Interest Coverage
7.69 -7.31 -178.76 -4.12
Return on Equity
-0.73 -9 11.14 -0.91
Return on Assets
-0.2 -0.38 -2.65 -0.64
Return on Invested Capital
-0.23 -0.47 -5.54 -0.54
Dividend Yield
99.72 n/a n/a n/a
Payout Ratio
-0.03 n/a n/a n/a
Gross Profit Margin
0.44 0.36 0.60 0.97
Net Profit Margin
-1.43 -2.66 -13.25 -1.6
Pretax Profit Margin
-1.4 -2.65 -13.24 -1.6
Operating Profit Margin
-1.24 -2.24 -12.92 -1.25
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-1.46 -2.28 -12.8 -1.25